Grace Li

Sponge on a string test to transform oesophageal cancer diagnosis

Barrett’s oesophagus is a condition that can lead to oesophageal cancer in a small number of people. It’s usually diagnosed in hospital by endoscopy (passing a camera down into the stomach) following a GP referral for longstanding heartburn symptoms. The Cytosponge test, developed by researchers at the University of Cambridge, is…...

Read more

Breakthrough discovery to transform prostate cancer treatment

A novel formulation of the prostate cancer drug abiraterone acetate — currently marketed as Zytiga — will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the new formulation improves the drug’s effectiveness by 40 per cent.…...

Read more

Popular chemotherapy drug may be less effective in overweight and obese women

Breast cancer patients who are overweight or obese might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients. An international team of researchers based this conclusion on a retrospective analysis of data from a large clinical trial. In most European countries, more than 50% of women…...

Read more

How cancer drugs find their targets could lead to a new toolset for drug development

In the watery inside of a cell, complex processes take place in tiny functional compartments called organelles. These compartments are bound by thin membranes. But in the past few years, research at Whitehead Institute and elsewhere has shown that there are other cellular organelles held together without a membrane. These…...

Read more

AACR Virtual Annual Meeting I presents new data on cancer biology, treatment, screening, risk reduction

Brief points covered in the America Association for Cancer Research (AACR) Virtual Annual Meeting I held on April 27-28th: -Treating BRAF-Positive Melanoma by adding checkpoint inhibitor Tecentriq (atezolizumab) to a combination of two targeted drugs Zelboraf (vemurafenib) and Cotellic (cobimetinib) -PARP Inhibitor (targeted drugs that inhibit DNA damage repair) are…...

Read more

Link between Children with Cancer and COVID-19

May 16th, 2020 A study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and researchers find that Medicaid expansion was associated with reduced cancer deaths. Read more at: https://www.cancertodaymag.org/Pages/cancer-talk/May-15-The-Week-in-Cancer-News.aspx...

Read more

FDA Approves Pemazyre (Pemigatinib) for Bile Duct Cancer

The US Food and Drug Administration (FDA) approved the first targeted therapy for bile duct cancer. Pemazyre (pemigatinib) is for adults with advanced bile duct cancer whose cancer has grown after at least one previous chemotherapy treatment and whose tumors have a mutation in the FGFR2 gene. Full information at: https://www.cancer.org/latest-news/fda-approves-pemazyre-pemigatinib-for-bile-duct-cancer.html...

Read more

FDA Approves Trodelvy (Sacituzumab govitecan-hziy) for Triple Negative Breast Cancer

The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded to other treatments. Triple-negative breast cancer is called that because the cancer cells don’t have estrogen or progesterone receptors and also…...

Read more

Common Questions About the New Coronavirus Outbreak

Cancer patients are among those at high-risk of serious illness from an infection because their immune systems are often weakened by cancer and its treatments. Although most people who were treated for cancer in the past (especially if it was years ago) are likely to have normal immune function, each…...

Read more

A combo of fasting plus vitamin C is effective for hard-to-treat cancers, study shows

Researchers have discovered that a fasting-mimicking diet could be more effective at treating some types of cancer when combined with vitamin C. In studies on mice, researchers found that the combination delayed tumor progression in multiple mouse models of colorectal cancer; in some mice, it caused disease regression. For full…...

Read more